147 related articles for article (PubMed ID: 19565204)
1. FAS and FAS ligand polymorphisms in the promoter regions and risk of gastric cancer in Southern China.
Wang M; Wu D; Tan M; Gong W; Xue H; Shen H; Zhang Z
Biochem Genet; 2009 Aug; 47(7-8):559-68. PubMed ID: 19565204
[TBL] [Abstract][Full Text] [Related]
2. Functional polymorphisms of the FAS/FASLG genes are associated with risk of alopecia areata in a Chinese population: a case-control analysis.
Fan X; Shangguan L; Li M; Li CY; Liu B
Br J Dermatol; 2010 Aug; 163(2):340-4. PubMed ID: 20394629
[TBL] [Abstract][Full Text] [Related]
3. Functional polymorphisms in FAS/FASL system increase the risk of neuroblastoma in Chinese population.
Han W; Zhou Y; Zhong R; Wu C; Song R; Liu L; Zou L; Qiao Y; Zhai K; Chang J; Huang L; Liu L; Lu X; Lou J; Yu D; Tan W; Zhang J; Wang H; Miao X
PLoS One; 2013; 8(8):e71656. PubMed ID: 23951214
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the FAS and FASL genes and risk of lung cancer in a Korean population.
Park SH; Choi JE; Kim EJ; Jang JS; Lee WK; Cha SI; Kim CH; Kam S; Kim DS; Park RW; Kim YC; Han SB; Jung TH; Park JY
Lung Cancer; 2006 Dec; 54(3):303-8. PubMed ID: 17014925
[TBL] [Abstract][Full Text] [Related]
5. Association between the FAS/FASL polymorphisms and gastric cancer risk: a meta-analysis.
Tian J; Pan F; Li J; Ma Y; Cen H; Pan HF; Pan YY; Ye DQ
Asian Pac J Cancer Prev; 2012; 13(3):945-51. PubMed ID: 22631677
[TBL] [Abstract][Full Text] [Related]
6. Functional polymorphisms in cell death pathway genes FAS and FAS ligand and risk of prostate cancer in a Chinese population.
Shao P; Ding Q; Qin C; Wang M; Tang J; Zhu J; Chen J; Cao Q; Li J; Xu B; Zhang Z; Zhang W; Yin C
Prostate; 2011 Jul; 71(10):1122-30. PubMed ID: 21557277
[TBL] [Abstract][Full Text] [Related]
7. Quantitative assessment of the association between Fas/FasL gene polymorphism and susceptibility to esophageal carcinoma in a north Chinese population.
Zhang M; Wu C; Li B; Du W; Zhang C; Chen Z
Cancer Med; 2016 Apr; 5(4):760-6. PubMed ID: 26819081
[TBL] [Abstract][Full Text] [Related]
8. Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case-control analysis.
Li C; Wu W; Liu J; Qian L; Li A; Yang K; Wei Q; Zhou J; Zhang Z
Pharmacogenet Genomics; 2006 Apr; 16(4):245-51. PubMed ID: 16538171
[TBL] [Abstract][Full Text] [Related]
9. Fas and FasL polymorphisms are not associated with acute myeloid leukemia risk in Koreans.
Kim HJ; Jin XM; Kim HN; Lee IK; Park KS; Park MR; Jo DY; Won JH; Kwak JY; Kim HJ; Choi JS; Juhng SW; Choi C
DNA Cell Biol; 2010 Oct; 29(10):619-24. PubMed ID: 20438363
[TBL] [Abstract][Full Text] [Related]
10. Single-nucleotide gene polymorphisms involving cell death pathways: a study of Chinese patients with lumbar disc herniation.
Sun Z; Ling M; Chang Y; Huo Y; Yang G; Ji Y; Li Y
Connect Tissue Res; 2013; 54(1):55-61. PubMed ID: 23205884
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of death pathway genes FAS and FASL and risk of premalignant gastric lesions.
Hsu PI; Lu PJ; Wang EM; Ger LP; Lo GH; Tsay FW; Chen TA; Yang HB; Chen HC; Lin WS; Lai KH
Anticancer Res; 2008; 28(1A):97-103. PubMed ID: 18383830
[TBL] [Abstract][Full Text] [Related]
12. Lack of association between gene polymorphisms of Angiotensin converting enzyme, Nod-like receptor 1, Toll-like receptor 4, FAS/FASL and the presence of Helicobacter pylori-induced premalignant gastric lesions and gastric cancer in Caucasians.
Kupcinskas J; Wex T; Bornschein J; Selgrad M; Leja M; Juozaityte E; Kiudelis G; Jonaitis L; Malfertheiner P
BMC Med Genet; 2011 Aug; 12():112. PubMed ID: 21864388
[TBL] [Abstract][Full Text] [Related]
13. The diplotype Fas -1377A/-670G as a genetic marker to predict a lower risk of breast cancer in Chinese women.
Xu Y; Deng Q; He B; Pan Y; Li R; Gao T; Sun H; Song G; Wang S; Cho WC
Tumour Biol; 2014 Sep; 35(9):9147-61. PubMed ID: 24916571
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms in the Fas and FasL genes are associated with epithelial ovarian cancer risk and clinical outcomes.
Li Y; Hao YL; Kang S; Zhou RM; Wang N; Qi BL
Gynecol Oncol; 2013 Mar; 128(3):584-9. PubMed ID: 23234803
[TBL] [Abstract][Full Text] [Related]
15. Quantitative assessment of the association between three polymorphisms in FAS and FASL gene and breast cancer risk.
Wang Z; Gu J; Nie W; Xu J; Huang G; Guan X
Tumour Biol; 2014 Apr; 35(4):3035-9. PubMed ID: 24248546
[TBL] [Abstract][Full Text] [Related]
16. FAS and FASLG polymorphisms and susceptibility to idiopathic azoospermia or severe oligozoospermia.
Wang W; Lu N; Xia Y; Gu A; Wu B; Liang J; Zhang W; Wang Z; Su J; Wang X
Reprod Biomed Online; 2009 Jan; 18(1):141-7. PubMed ID: 19146781
[TBL] [Abstract][Full Text] [Related]
17. Association of the polymorphisms in the Fas/FasL promoter regions with cancer susceptibility: a systematic review and meta-analysis of 52 studies.
Xu Y; He B; Li R; Pan Y; Gao T; Deng Q; Sun H; Song G; Wang S
PLoS One; 2014; 9(3):e90090. PubMed ID: 24598538
[TBL] [Abstract][Full Text] [Related]
18. Functional polymorphisms in FAS, FASL and CASP8 genes and risk of childhood acute lymphoblastic leukemia: a case-control study.
Tong N; Zhang L; Sheng X; Wang M; Zhang Z; Fang Y; Xue Y; Li J; Zhang Z
Leuk Lymphoma; 2012 Jul; 53(7):1360-6. PubMed ID: 22211869
[TBL] [Abstract][Full Text] [Related]
19. [Genetic polymorphisms of apoptosis-associated genes FAS and FASL and risk of colorectal cancer].
Yang S; Miao XP; Zhang XM; Sun T; Qu SN; Xiong P; Ye YJ; Guo YL; Tan W; Wang S; Lin DX
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2132-5. PubMed ID: 16313826
[TBL] [Abstract][Full Text] [Related]
20. Functional polymorphisms in FAS and FASL contribute to risk of squamous cell carcinoma of the larynx and hypopharynx in a Chinese population.
Wang J; Gao J; Li Y; Zhao X; Gao W; Peng L; Yan D; Liu L; Li D; Wei L; Qi J; Zhou C
Gene; 2013 Jul; 524(2):193-6. PubMed ID: 23618817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
